As constant reinfection of hepatocytes is thought to play a major role in HDV persistence, the strong inhibition of virion production and spreading following treatment with FXR ligands opens promising therapeutic perspectives for these molecules in the treatment of hepatitis delta. The gene discussed is NR1H4; the disease is hepatitis D virus infection.